Viet D. Vu

Array ( [id] => 3695963 [patent_doc_number] => 05618837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'PDGF antagonists III' [patent_app_type] => 1 [patent_app_number] => 8/483216 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618837.pdf [firstpage_image] =>[orig_patent_app_number] => 483216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621106 [patent_doc_number] => 05688784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Method of suppressing appetite with vanadium complexes' [patent_app_type] => 1 [patent_app_number] => 8/484970 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9749 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688784.pdf [firstpage_image] =>[orig_patent_app_number] => 484970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510083 [patent_doc_number] => 05587366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Compositions useful in prophylaxis and therapy of endotoxin related conditions' [patent_app_type] => 1 [patent_app_number] => 8/487461 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 5964 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587366.pdf [firstpage_image] =>[orig_patent_app_number] => 487461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662409 [patent_doc_number] => 05656667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Fatty acid composition' [patent_app_type] => 1 [patent_app_number] => 8/471200 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5070 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656667.pdf [firstpage_image] =>[orig_patent_app_number] => 471200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657174 [patent_doc_number] => 05648086 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Stable solid form antimicrobial compositions comprising 3-isothiazolones' [patent_app_type] => 1 [patent_app_number] => 8/471888 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1967 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648086.pdf [firstpage_image] =>[orig_patent_app_number] => 471888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3547660 [patent_doc_number] => 05545638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Method of treating gastrointestinal motility disorders' [patent_app_type] => 1 [patent_app_number] => 8/468272 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31821 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 375 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545638.pdf [firstpage_image] =>[orig_patent_app_number] => 468272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689056 [patent_doc_number] => 05643951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders' [patent_app_type] => 1 [patent_app_number] => 8/465608 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2467 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643951.pdf [firstpage_image] =>[orig_patent_app_number] => 465608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695597 [patent_doc_number] => 05661131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Treatment of cholera' [patent_app_type] => 1 [patent_app_number] => 8/442457 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10403 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661131.pdf [firstpage_image] =>[orig_patent_app_number] => 442457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510851 [patent_doc_number] => 05563164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Phospholipase A.sub.2 inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/464030 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18763 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 327 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563164.pdf [firstpage_image] =>[orig_patent_app_number] => 464030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623680 [patent_doc_number] => 05686114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Uses of inorganic pyrophosphates' [patent_app_type] => 1 [patent_app_number] => 8/484847 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 11591 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686114.pdf [firstpage_image] =>[orig_patent_app_number] => 484847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3492682 [patent_doc_number] => 05536715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-16 [patent_title] => 'Combinations of anthelmintically active agents' [patent_app_type] => 1 [patent_app_number] => 8/457734 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1929 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/536/05536715.pdf [firstpage_image] =>[orig_patent_app_number] => 457734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621347 [patent_doc_number] => 05614542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/456287 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3163 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614542.pdf [firstpage_image] =>[orig_patent_app_number] => 456287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706149 [patent_doc_number] => 05654278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Composition and method comprising growth hormone and leucine' [patent_app_type] => 1 [patent_app_number] => 8/455886 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3220 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654278.pdf [firstpage_image] =>[orig_patent_app_number] => 455886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590316 [patent_doc_number] => 05585402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Nitric oxide synthase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/452367 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3443 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585402.pdf [firstpage_image] =>[orig_patent_app_number] => 452367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622203 [patent_doc_number] => 05593971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method for preventing onset of hypertension employing a cholesterol lowering drug' [patent_app_type] => 1 [patent_app_number] => 8/445621 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7864 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593971.pdf [firstpage_image] =>[orig_patent_app_number] => 445621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510724 [patent_doc_number] => 05563156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Thrombin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/444245 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19156 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 309 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563156.pdf [firstpage_image] =>[orig_patent_app_number] => 444245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665612 [patent_doc_number] => 05597822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Pharmaceutical compositions for the prevention and/or treatment a gastrointestinal diseases' [patent_app_type] => 1 [patent_app_number] => 8/443487 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4726 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597822.pdf [firstpage_image] =>[orig_patent_app_number] => 443487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621774 [patent_doc_number] => 05620705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Progestin tablet' [patent_app_type] => 1 [patent_app_number] => 8/441889 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3592 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620705.pdf [firstpage_image] =>[orig_patent_app_number] => 441889 [rel_patent_id] =>[rel_patent_doc_number] =>)